PRKCQ inhibition enhances chemosensitivity of triple-negative breast cancer by regulating Bim.

Jessica H ByerlyElisa R PortHanna Y Irie

Published in: Breast cancer research : BCR (2020)

These studies support PRKCQ inhibition as an attractive therapeutic strategy and complement to chemotherapy to inhibit the growth and survival of TNBC cells.

Keyphrases

induced apoptosis
cell cycle arrest
endoplasmic reticulum stress
locally advanced
squamous cell carcinoma
case control
oxidative stress
free survival
pi k akt
chemotherapy induced